Related Experiment Video
Updated: Jun 4, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
Sarcoidosis and small-fiber neuropathy
1Cleveland Clinic Foundation, Neuromuscular Center, 9500 Euclid Avenue, S90, Cleveland, OH 44195, USA. taveej2@ccf.org
Abstract:
Chronic pain is one of the most commonly reported symptoms among sarcoidosis patients. Not only does it significantly affect quality of life, but it also is a source of frustration for both the patient and physician because the etiology for pain often is unknown. Although patients typically complain of neuropathic-type pain, nerve conduction studies and other conventional diagnostic procedures frequently fail to reveal objective evidence of neurologic disease. However, in recent years, the growing use of specialized tests such as skin biopsy and sudomotor testing has helped to establish the diagnosis of small-fiber neuropathy as the cause of pain in these patients via objective and quantifiable means. Management of sarcoidosis small-fiber neuropathy should consist of target-directed treatment of the underlying disease and appropriate symptomatic therapy.
Related Concept Videos
Diabetic Neuropathy
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Fungal Phylum Microsporidia
Myasthenia Gravis ll: Pathophysiology
Sympathetic Pathways: Sympathetic Chain Ganglia
Multiple Sclerosis l: Introduction
